Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02721446 · ClinicalTrials.gov registry record · NA

MINDSPACE Strategy for Risk Optimization

A NA study of Stroke, sponsored by Indiana Institute for Medical Research.

Completed
Registry status
NA
Development phase
641
Enrollment target
1
Study location

NCT02721446: Completed NA study of Stroke, sponsored by Indiana Institute for Medical Research.

NCT02721446 is a NA study of Stroke that has completed, run by Indiana Institute for Medical Research. The registered enrollment target is 641 participants, below the 12,015-participant average among 454 other Stroke trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT02721446, a NA study of Stroke, has completed, sponsored by Indiana Institute for Medical Research.

COMPLETED
Registry status
NA
Development phase
641 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to find out which types of written stroke messages may help high risk stroke patients take action to improve their health.

Primary Outcome

The primary outcome is the proportion responding to the mailings in each of the four intervention groups. Investigators will calculate the denominator as the number of patients that were sent a mailing (mailing was not returned as undeliverable and patient did not opt out) and the numerator as the number of these mailings that generate a telephone call response. Investigators will track whether the response occurs after the first, second, or third mailing to estimate the utility of subsequent ma

Conditions Studied

Stroke

Interventions

  • BEHAVIORAL Incentive
  • BEHAVIORAL Standard
  • BEHAVIORAL Salience
  • BEHAVIORAL Incentive + Salience

Study Locations (1)

Indiana

  • Richard L. Roudebush VA Medical Center - Indianapolis

Trial Details

FieldValue
Enrollment Target 641 participants
Start Date 2016-06
Est. Completion 2018-08
Phase NA
Indiana Institute for Medical Research

1 total trials

What the finished NCT02721446 record still lists

NCT02721446 is an interventional study that assigns participants to a tested intervention. The registered 641 participants enrollment target is mid-sized for trials with a published cap, below the 12,015-participant average among 454 other Stroke trials with a reported enrollment target (95% lower).

The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 4 interventions - of which Incentive is the first listed.

NCT02721446 reports a single indexed study location in Indiana.

Frequently Asked Questions

What is clinical trial NCT02721446 about?

NCT02721446 is a clinical study titled "MINDSPACE Strategy for Risk Optimization". The purpose of this study is to find out which types of written stroke messages may help high risk stroke patients take action to improve their health.

What is the current status of trial NCT02721446?

This trial is currently completed. It is a NA study. The enrollment target is 641 participants. The study started on 2016-06. Estimated completion is 2018-08.

What conditions does trial NCT02721446 study?

This clinical trial studies the following conditions: Stroke.

What interventions are being tested in trial NCT02721446?

The interventions under investigation include: Incentive (BEHAVIORAL), Standard (BEHAVIORAL), Salience (BEHAVIORAL), Incentive + Salience (BEHAVIORAL).

Who is sponsoring clinical trial NCT02721446?

This trial is sponsored by Indiana Institute for Medical Research, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02721446 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02721446's enrollment target sits among peer trials

641 47th of 454 higher than 408 of 454 other Stroke trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06319820 · 641 participants · Phase 3

    A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer

  • NCT06625060 · 641 participants · Phase 2

    A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults

  • NCT05204888 · 642 participants · NA

    myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home

  • NCT04339699 · 640 participants · NA

    NobleStitch EL STITCH Trial is a PFO Comparative Trial

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Related registry views

Source: ClinicalTrials.gov NCT02721446, the US trial registry maintained by the National Library of Medicine. NCT02721446 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.